W
WAVEMAN · COMPANY
IMA · Imagenebio, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

IMA

ImageneBio, Inc.
PHARMA & BIOTECH · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · CIK 0001835579
ACTIVIST 13D☆ WATCH
INSIDER NET · 180D
-$17.3K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
14
13F, latest reported quarter
REVENUE GROWTH
-77.1%
XBRL, annual
NET MARGIN
-
CONVERSIONS · 180D
1
codes C/M, not in net · $0 priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$17.3K over 180 days
-$17.3K over 90 days
more than 61% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
14 funds added or opened last quarter
below 75% of Pharma & Biotech
REVENUE
-77.1% year over year
below 89% of Pharma & Biotech
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
3.4% of shares outstanding short · 29.6 days to cover · settled 2026-07-31
below 55% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Omega Fund VI, L.P. disclosed a 5%+ stake (8.4%) in the last six months.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -63.4%
-63.4%12M
-66%-43%-20%+3%2025-092025-102025-122026-032026-052026-072026-09 2025-12-24 · SLATTERY JOSEPH P bought $95.8K2026-07-16 · Lally Robert B sold $9.2K2026-07-17 · Lally Robert B sold $8.1K2026-04-21 · Omega Fund VI, L.P. filed a 5%+ stake (8.4%)2026-04-21 · Omega Fund VI GP, L.P. filed a 5%+ stake (8.4%)2026-04-21 · Omega Fund VI GP Manager, Ltd. filed a 5%+ stake (8.4%)2026-04-21 · Claudio Nessi filed a 5%+ stake (8.4%)2026-04-21 · Otello Stampacchia filed a 5%+ stake (8.4%)
INSIDER BUYINSIDER SELL13D/G STAKE
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
An activist crossed the 5% line with declared intent.
The record shows a net $17.3K sold by insiders over 180 days, 14 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, ImageneBio, Inc. insiders sold a net $17.3K of stock across 5 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Lally Robert B
Principal Accounting Officer
SELL
2026-07-17
1,525.0
$8.1K
Lally Robert B
Principal Accounting Officer
SELL
2026-07-16
1,671.0
$9.2K
SLATTERY JOSEPH P
Director
BUY
2025-12-24
16,000.0
$95.8K
Bonita David P
Director
BUY
2025-07-25
83,611.0
$2.5M
Stampacchia Otello
Director
BUY
2025-07-25
267,556.0
$8.0M
5 TRANSACTIONS ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BVF INC/IL
1,110,002.0 sh
$6.5M
Blue Owl Capital Holdings LP
917,692.0 sh
$5.4M
ORBIMED ADVISORS LLC
909,269.0 sh
$5.4M
Cable Car Capital, LP
781,599.0 sh
$4.6M
Omega Fund Management, LLC
455,361.0 sh
$2.7M
5%+ owners
13D = intent to influence · 13G = passive
Omega Fund VI, L.P.
ACTIVIST 13D · 2026-04-21
8.4%
Omega Fund VI GP, L.P.
ACTIVIST 13D · 2026-04-21
8.4%
Omega Fund VI GP Manager, Ltd.
ACTIVIST 13D · 2026-04-21
8.4%
Claudio Nessi
ACTIVIST 13D · 2026-04-21
8.4%
Otello Stampacchia
ACTIVIST 13D · 2026-04-21
8.4%
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
iShares Micro-Cap ETF
$103.6K POSITION · AS OF 2026-03-31
0.0%
1290 VT Micro Cap Portfolio
$8.1K POSITION · AS OF 2026-03-31
0.0%
Fidelity Extended Market Index Fund
$183.4K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$263.3K POSITION · AS OF 2026-03-31
0.0%
VANGUARD TOTAL STOCK MARKET INDEX FUND
$1.3M POSITION · AS OF 2026-03-31
0.0%
VANGUARD BALANCED INDEX FUND
$38.6K POSITION · AS OF 2026-03-31
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$800.0K$3.5M$9.2M$15.6M
OPERATING INCOME$-48.5M$-37.0M$-75.4M$-70.9M
NET INCOME$-45.3M$-36.6M$-68.2M$-68.8M
EPS (DILUTED)-9.64-22.10-1.63-1.90
OPERATING CASH FLOW$-47.8M$-21.3M$-79.7M$-74.1M
CASH$94.5M$12.1M$119.9M$59.9M
BUYBACKS$663.0K
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →